Bray Capital Advisors Sells 190,000 Shares of American Well Co. (NYSE:AMWL)

Bray Capital Advisors decreased its position in American Well Co. (NYSE:AMWL) by 95.0% in the third quarter, HoldingsChannel.com reports. The institutional investor owned 10,000 shares of the company’s stock after selling 190,000 shares during the quarter. Bray Capital Advisors’ holdings in American Well were worth $95,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. Point72 DIFC Ltd lifted its position in American Well by 1,418.5% in the second quarter. Point72 DIFC Ltd now owns 103,457 shares of the company’s stock valued at $34,000 after purchasing an additional 96,644 shares during the last quarter. Cubist Systematic Strategies LLC lifted its position in American Well by 7,673.8% in the second quarter. Cubist Systematic Strategies LLC now owns 184,083 shares of the company’s stock valued at $60,000 after purchasing an additional 181,715 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. lifted its position in American Well by 2,690.2% in the second quarter. Point72 Asia Singapore Pte. Ltd. now owns 419,841 shares of the company’s stock valued at $136,000 after purchasing an additional 404,794 shares during the last quarter. AQR Capital Management LLC lifted its position in American Well by 28.1% in the second quarter. AQR Capital Management LLC now owns 1,895,730 shares of the company’s stock valued at $616,000 after purchasing an additional 416,387 shares during the last quarter. Finally, Renaissance Technologies LLC lifted its position in American Well by 63.9% in the second quarter. Renaissance Technologies LLC now owns 6,833,500 shares of the company’s stock valued at $2,220,000 after purchasing an additional 2,665,300 shares during the last quarter. Institutional investors own 56.05% of the company’s stock.

Insider Activity at American Well

In related news, insider Kathy Johnson Weiler sold 7,266 shares of the company’s stock in a transaction on Tuesday, September 3rd. The stock was sold at an average price of $7.87, for a total value of $57,183.42. Following the sale, the insider now directly owns 188,027 shares of the company’s stock, valued at $1,479,772.49. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In related news, CFO Robert Shepardson sold 5,177 shares of the company’s stock in a transaction on Tuesday, September 3rd. The stock was sold at an average price of $7.87, for a total value of $40,742.99. Following the sale, the chief financial officer now directly owns 112,992 shares of the company’s stock, valued at $889,247.04. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Kathy Johnson Weiler sold 7,266 shares of the stock in a transaction on Tuesday, September 3rd. The stock was sold at an average price of $7.87, for a total value of $57,183.42. Following the completion of the sale, the insider now directly owns 188,027 shares in the company, valued at approximately $1,479,772.49. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 21,640 shares of company stock worth $173,939 over the last quarter. 12.80% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

AMWL has been the subject of several recent research reports. Needham & Company LLC reiterated a “hold” rating on shares of American Well in a research report on Thursday, October 31st. Wells Fargo & Company decreased their target price on American Well from $40.00 to $15.00 and set an “equal weight” rating for the company in a report on Tuesday, August 6th.

American Well Stock Down 2.1 %

Shares of American Well stock opened at $8.79 on Friday. The company has a market cap of $131.76 million, a PE ratio of -0.60 and a beta of 1.04. The business has a 50 day moving average of $9.40 and a 200 day moving average of $8.91. American Well Co. has a 52 week low of $5.00 and a 52 week high of $31.60.

American Well Profile

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members.